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Objectives. To explore the safety and eﬃcacy of mini-margin nephron sparing surgery (NSS) for renal cell carcinoma (RCC) 4cm
or less. Methods. Total of 389 cases of RCC 4cm or less with normal contralateral kidneys were included in the study, including
135 cases treated by mini-margin NSS, 98 by 1cm-NSS and 156 by radical nephrectomy (RN). The clinical results were followed-
up and comparatively analyzed. Results. The mean and median margin width for mm-NSS was 2.2 and 2.0mm (range 0 to 5).
Of them, 112 (83.0%) cases had margins of 3mm or less, and 26 had margins of 0mm (19.3%). The mean width of margin for
1cm-NSS was 11.6mm (median 12, range 10∼15). None of the NSS patients had positive surgical margins. The mean follow-up
for mm-NSS, 1cm-NSS and RN patients was 69, 82 and 82 months, respectively. Three mm-NSS patients, two 1cm- NSS and four
RN patients died of non-cancer related causes. Two mm-NSS patient (1.6%) experienced local recurrence. No distant metastasis
was detected in all the patients. The over all 5-year survivals for NSS and RN patients were 100%, 100% and 98.7%, respectively
(P = .950). Conclusions. Mini-margin NSS is as safe and eﬀective as 1cm-NSS and RN in treating early localized RCC 4cm or less.
1.Introduction
Nephron sparing surgery (NSS) has proven to be a safe
and eﬀective approach for renal cell carcinoma (RCC), with
comparableclinicalresultstoradicalnephrectomy,especially
for the tumors 4cm or less, even in patients with completely
normal opposite kidneys. For many years, surgical practice
for NSS was to have a more than 1cm margin of normal
tissue around the tumor [1, 2]. However, more recent studies
show that the width of the margin seems not important.
N S Sw i t has m a l l e rm a r g i ni sa sw e l ls a f ea n de ﬀective in
tumor control [3]. And even pure enucleation is as eﬀective
aspartialnephrectomywitharimofhealthyparenchyma[4].
From January 1998 to December 2008, based on the
previous studies in our institute, 135 cases of RCC 4cm
or less in diameter and staged as T1aN0M0 with normal
contralateral kidney were treated with 5mm mini-margin
NSS (mm-NSS). The clinical results were followed and
compared with 99 cases of NSS with margin 1cm or more
(1cm-NSS) and 156 cases of radical nephrectomy (RN) for
RCC of same stage. The Data were comparatively analyzed
to evaluate the safety and eﬃcacy of mini-margin NSS in
treating early localized RCC 4cm or less.
2.MaterialsAnd Methods
2.1. Patient Selection. Only patients with RCC 4cm or less,
with normal contralateral kidney, without lymph node or
distant metastasis detected before and during the operation,
and clinically Stage T1aN0M0 were included in the analysis.
All cases were conﬁrmed by histologic evaluation to be RCC,
pathologic Stage T1aN0M0.
Patients with renal impairment, previous nephrectomy,
bilateral or multiple RCCs were excluded. Cases with
benign or other type of malignancies such as transitional
cell carcinoma rather than RCC revealed at postoperative
pathologic examination. And those with nodal or distant
metastasis and fat invasion detected before the operation by
imaging technique or during the operation by frozen section
analysis were also excluded. However, patients with nodal or
distant metastasis detected after partial nephrectomy were
not excluded.2 Advances in Urology
From January 1998 to December 2008, 395 cases of
RCC 4cm or less undergone surgical treatment in author’s
institute, including 140 cases treaded with mm-NSS, 98 with
1cm-NSS and 157 with RN.
Patients underwent 1cm-NSS and RN were mainly from
the earlier time, as in recent years most cases with RCC T1a
werepreferablytreatedwithmm-NSS.Centrallocationalone
orinvasiontothecalyxwasnotasuﬃcientreasontoperform
RN.
Thus, there were 5 patients (mm-NSS) with synchronous
bilateralRCC,and1patient(RN)withpositiveregionalnode
revealedbypathologicanalysiswereexcludedfromthestudy.
2.2. Histopathology. All cases were staged, classiﬁed, and
gradedaccordingtoTNMcriteria2002,UICCnewclassiﬁca-
tion system 1997 and Fuhrman nuclear grading system. Only
patients with histologically conﬁrmed RCC were included in
the analysis.
2.3. mm-NSS. In the remaining 135 cases of NSS, there
were 106 males and 29 females, with an average age of 57
(median 56, range 41∼73). All the cases were with normal
contralateral kidneys. Of the 135 tumors, 125 tumors were
peripherally located (with 105 cases at upper or lower pole
of the kidneys and 20 at the middle part) whereas 10 tumors
were centrally located.
Preoperatively, all the patients treated with mini-margin
NSS were informed of the surgery and asked to sign the
permission paper. The surgical procedure for mini-margin
NSS was as described in previous reports [5]. The kidney
capsule was sharply incised less than 5mm away from
tumor pseudocapsule and the tumor was enucleated with an
anticipated margin of less than 5mm. Renal hypothermia
with ice slush was used when a prolonged ischemia time
(longer than 30 minutes) was anticipated, such as for cen-
trally located tumors. To prevent renal ischemic damage, all
patients were vigorously hydrated and infused with mannital
a few minutes before vessel occlusion and furosemide was
adopted following clamp removing.
After removing the tumor, the sample was meticulously
checked for gross margin status. When no renal parenchyma
was present outside the pseudocapsule, additional thin layer
of renal parenchyma was resected for margin patholog-
ical evaluation. The frozen section analysis included the
pathologic diagnosis, margin width, and determination of
possible residual tumor. The maximal and minimal distances
from the cut edge of the renal parenchyma to the tumor
pseudocapsule were measured for each case. When no renal
parenchyma was present outside the pseudocapsule, the
margin width was recorded as zero.
2.4. 1cm-NSS. Ninety-eight cases of RCC 4 cm or less were
treated with 1cm-NSS, including 75 cases of male and 23
of female, with an average age of 60 (median 59, range 46∼
70). All the patients were with unilateral RCC and normal
contralateral kidneys. Surgical procedure of 1cm-NSS was
similar to mm-NSS, but tumor was incised 1cm or more
away from pseudocapsule. Margin evaluation was done as
described for mm-NSS.
2.5. RN. In the 156 cases of RN included, there were 117
males and 39 females, with an average age of 59 (median 59,
range 45∼75). All the patients were with unilateral RCC and
normal contralateral kidneys. Surgical procedure for RN was
routinely performed as standard technique.
2.6. Followup. The ﬁrst time followup was executed 3
months after NSS or RN, and CT scanning was done for
evaluation of the kidney’s morphologic changes and for
thereafter reference in NSS patients but not in RN. The
regular followup afterward for both groups of patients was
conducted every 3∼6monthsinrefertorenalfunction,urine
routine test, kidney ultrasound, and chest X-ray. CT scan or
MRI of the kidneys and chest was performed annually, or at
any time in cases of clinical suspicion by ultrasonography or
X-ray.
2.7. Statistical Analyses. Comparisons of features between
patients treated with NSS and RN were evaluated using
the chi-square, Fisher’s exact and t-test. Overall and
cancer-speciﬁc survivals were estimated using Kaplan-Meier
method. Statistical analyses were performed using SPSS 13.0
software package. All tests were 2-sided and P<. 05 was
considered statistically signiﬁcant.
3. Results
The clinicopathologic characteristics of the three groups
of patients are reported in Table 1. The groups were well
matched for patients’ sex, tumor size, nuclear grade, histo-
logic classiﬁcation. The mean age of RN patients was higher
than that of NSS patients (P = .018) as surgeons were more
likely to choose younger patients for conservative surgery.
All surgical procedures were technically successful either
for NSS or RN. The mean duration of the whole surgical
procedure and mean estimated blood loss were 85 minutes
(range 60∼90) and 60mL (range 50∼80) for mm-NSS, 95
minutes (range 70–110) and 70mL (50–100) for 1-cm NSS,
and 60 minutes (range 50∼80) and 20mL (range 10∼50) for
RN. No intraoperative complications occurred for both the
group of patients. None of the patients died within the ﬁrst
30 days after surgery.
Staging lymphadenectomy was performed in 7 cases
when enlarged regional lymph nodes were found during
surgery. Malignancy was detected in one RN case (nodal
metastasis) on pathologic analysis and this case was excluded
from the study.
3.1. mm-NSS. Renal vessel occlusion was used in 108
patients and simple parenchyma compression in 27 for
bleeding control. Renal hypothermia with ice slush was used
in 32 patients (23.7%), but it was unnecessary in most
cases. The mean hypothermia ischemia time was 21 minutes
(median 22, range 20 to 35). Warm ischemia surgery wasAdvances in Urology 3
Table 1: Comparisons of the clinical and pathological features.
mm-NSS 1cm-NSS RN P Value
No. of Pts 135 98 156
Pts age at surgery (yr)
Mean 57 60 59 .018
Median (range) 56 (41∼73) 59 (46∼70) 59 (45∼75)
No. male 106 (78.5%) 75 (76.5%) 117 (75.0%) .779
Tumor size (cm)
Mean 3.3 2.9 3.0 .513
Median (range) 3.5 (1.0∼4.0) 3.2 (1.0∼4.0) 3.3 (1.5∼4.0)
Fuhrman nuclear grade
G1+2 130 (96.3%) 96 (98.0%) 151 (96.8%) .764
Histologic classiﬁcation
Clear cell RCC 105 (77.8%) 78 (79.6%) 125 (80.1%) .880
Surgical margin (mm)
Mean (median, range) 2.2 (2.0, 0∼5) 11.6 (12, 10∼15) — .000∗
Complication rate 0.7% (1/135) 5.1% (5/98) — .049∗
Followup (months)
Mean (median, range) 69 (73, 15∼130) 82 (82, 60∼103) 82 (78, 23∼134) .000
RCC = renal cell carcinoma, pts=patients; ∗compared between mm-NSS and 1cm-NSS groups.
used in 103 patients (76.3%). The mean warm ischemia time
was 16 minutes (median 18, range 7 to 22).
The mean and median diameters of the tumors were
3.3 and 3.5cm (range 1.0 to 4.0). All cases were stage
T1aN0M0. Using the Fuhrman nuclear grading system,
53 (39.3%) of the tumors were G1, 77 (57.0%) G2, 5
(4.3%) G3, and none G4. Renal clear cell carcinoma was
conﬁrmed in 105 patients (77.8%), papillary RCC in 18
(13.3%),chromophoberenalcellcarcinomain9(6.7%),and
multicystic clear cell renal cell carcinoma in 3 (2.2%).
None of the patients had positive surgical margins
detected on pathologic examination, frozen section analysis,
or ﬁnal paraﬃn section analysis. The minimal margin was
always at the bottom of the tumor, where the mean actual
margin thickness was 2.2mm (median 2.0, range 0 to 5).
The maximal margin was always at the area of the renal
capsule, where the mean actual margin was 4.5mm (median
5.0, range 4 to 6). If considering the minimal margin only in
the analysis, all the cases had a margin of 5mm or less, 112
(83.0%) had margins of 3mm or less, and 26 had margins of
0mm (19.3%).
One patient (0.7%) experienced slight secondary gross
hematuria 2 weeks after surgery but no arteriovenous ﬁstula
or pseudoaneurysm was detected on computed tomography
angiography. This patient was treated conservatively without
the need for blood transfusion or surgical intervention. No
major complications such as urinary leakage, urinoma, or
hemorrhage requiring reoperation occurred.
3.2. 1cm-NSS. The mean and median diameter of the 98
tumors treated by 1cm-NSS was 2.9 and 3.2cm (range 1.0∼
4.0). All cases were stage T1aN0M0. The Fuhrman nuclear
grading was G1 in 31 cases (31.6%), G2 in 65 (66.3%), G3
in 3 (3.1%), and none G4. Renal clear cell carcinoma was
conﬁrmed in 78 (79.6%) cases, papillary RCC in 15 (15.3%),
chromophobe RCC in 4 (4.1%), and multicystic clear cell
renal cell carcinoma in 1 (1.0%).
None of the patients had positive surgical margins
detected pathologically. The mean margin thickness was
11.6mm (median 12.0, range 10 to 15).
Collecting system open occurred in 25 patients and
urinary leakage developed in 3. Two of them were cured
conservativelyand1wascuredbyDouble-Jstentinstallation.
No serious hemorrhage requiring reoperation occurred. NSS
had to be turned to radical nephrectomy in 2 patients with
centrallylocatedtumorsduetodamageofmainbloodsupply
vessel or renal pelvis which was unable to repair. The overall
complication rate was (5/98, 5.1%). The average size of these
tumors was 3.6cm (range 3.0∼4.0).
3.3. RN. In the 156 cases of RCC treated by RN, the mean
and median diameters of the tumors were 3.0 and 3.3cm
(range, 1.5∼4.0). All cases were stage T1aN0M0. On the
basis of Fuhrman nuclear grading system, 56 (35.9%) of the
tumors were G1, 95 (60.9%) G2, 5 (3.4%) G3, and none
G4. Renal clear cell carcinoma was conﬁrmed in 125 (80.1%)
cases, papillary RCC in 23 (14.7%), and chromophobe RCC
in 8 (5.1%). No major complication occurred.
3.4. Followup and Survivals. Until last evaluation in Decem-
ber 2009, the mean followup for mm-NSS, 1cm-NSS,
and RN groups was 69 months (median 73, range 15 to
130), 82 months (median 82, 60∼103), and 82 months
(median 78, range 23 to 134), respectively. Three mm-NSS
patients died 77, 88 and 104 months after operation, two
1cm-NSS patients died 81, 95 months after surgery and
four RN patients died 47, 66, 76, and 106 months post
operation, but none of them cancer related. Two mm-NSS4 Advances in Urology
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Figure 1: Overall survival for 135 patients treated with mm-NSS,
98 patients with 1cm-NSS and 156 patients with RN.
patient (1.5%) experienced local recurrence, including one
of ectopic recurrence in the same kidney and one of tumor
bed recurrence. The ectopic recurrence occurred 32 months
after NSS at a diﬀerent site away from the original tumor
bed. The original tumor of 3.5cm (clear cell type and G2)
was located at the lower pole of the kidney, and the recurrent
tumor (also clear cell type and G2) was detected at the upper
pole 32 months after NSS. The case of tumor bed recurrence
wasdetected25monthsaftermm-NSSandthemarginwidth
of this case was 4mm. Both patients were cured by remedial
radical nephrectomy in respect of the patient’s choice, with
no evidence of disease at the last followup visit. No local
recurrenceoccurredinpatientstreatedby1cm-NSSandRN.
No distant metastasis was detected in the three groups of
patients.
Using Kaplan-Meier survival analyses, the overall 5-year
survivals for mm-NSS, 1cm-NSS, and RN patients were
100%, 100% and 98.7% (see Figure 1), Log Rank statistic
0.102, P = .950. Cancer speciﬁc survivals were not estimated
as none of patients’ death in both groups was cancer-related.
Recurrence-free survival analysis was also not performed
as only two mm-NSS patients had local recurrence during
followup.
4. Discussion
In recent decades, the excellent cancer speciﬁc survival
which has been reported for imperative NSS has led to the
increased use of NSS in cases without imperative indications
for conservative surgery. There are extensive reports to
support elective NSS for renal masses 4cm or smaller in
greatest dimension [6–8]. Cancer-speciﬁc and metastases-
free survival are comparative between patients treated with
NSS and RN for small early RCC [9, 10], and complication
rates, morbidity and mortality are similar for NSS and RN
[11, 12], while NSS provides better preservation of renal
function than RN [9].
What must be minimized with nephron sparing surgery
is the possibility of local recurrences. It has been suggested
that at least some local recurrence after partial nephrectomy
may be due to residual tumor cells on the tumor bed. Based
on the assumption, resection of the tumor with a 1-cm
margin of normal-appearing parenchyma around the tumor
had been considered the standard surgical technique for NSS
for many years [1, 2]. However, the size of the surgical
margin that should be removed with the tumor remains
controversial. An optimal margin will guarantee complete
tumor removal as well as keep local recurrence rates to
a minimum. An over-resected margin could increase the
surgical diﬃculty and compromise residual renal function,
especially in the case of a solitary kidney. It could also
increase the morbidity of any surgical complications. In a
retrospective study of 69 patients who had undergone NSS,
Castilla et al. [13] found, after a mean followup of 8.5 years,
that a histologic tumor-free resection margin was suﬃcient
to achieve complete local RCC control and that the width
of the resection margin did not correlate with long-term
disease progression. Piper et al. [14] reported that a 1-mm
margin of normal tissue is necessary to prevent recurrence in
a study of 67 patients with a mean followup of 60 months.
Accordingly, Sutherland et al. [15] investigated the eﬀects
of surgical margin size on recurrence in 44 patients who
had undergone partial nephrectomy. The mean and median
negative margin was 2.5mm and 2mm (range 0.5 to 7),
respectively. They concluded that as long as the tumor bed
w a sf r eeo fr e s i d u a lt u m o r ,t h em a r gi ns i z ew a si rr el ev a n ta n d
did not correlate with disease progression during NSS for
low-stage RCC. Recently, Akc ¸etin et al. [3] also found that
an increased margin was not clinically related to patients’
survival if the margin was greater than 2mm. Similar results
were reported by Timsit et al. [16] and Berdjis et al. [17].
In a prospective study of Stage pT1a RCC treated with
radical nephrectomy, Li et al. [18] found positive cancer
lesions beyond the pseudocapsule in 19.5% of patients, with
an average distance from the primary tumor of 0.5mm
(standard deviation 1.3, range 0 to 5.0), and concluded that
when partial nephrectomy was performed, a 5-mm margin
could be enough to prevent local recurrence. More recent
studies even showed that pure enucleation is as eﬀective as
partial nephrectomy with a rim of healthy parenchyma [4].
In the present study, mm-NSS was performed using a
margin of less than 5mm, with most patients having a
margin of less than 3mm (83.0%), including 26 patients
with 0-mm margins at the tumor bottom (19.3%). The
median margin was only 2mm, but no positive surgical
margin was detected. Also, the long-term followup showed
a comparative overall survival with 1cm-NSS and radical
nephrectomy. And no patient in three groups died of cancer-
related causes and no metastasis detected during followup.Advances in Urology 5
Only 1 NSS patient developed local recurrence at tumor bed.
O n ec a s eh a dt u m o rr e c u r r e n c ei nad i ﬀerent site away from
theoriginaltumorbed.Thiscaseofectopicrecurrencemight
havebeenduetotumormultifocality.Ourstudyalsoshowsa
signiﬁcant lower complication rate in mm-margin NSS than
that in 1cm-NSS.
These data show that mini-margin NSS with a less than
5-mm margin can eﬀectively achieve local tumor resection
with excellent long-term patient survival for those with RCC
of 4 cm or less (T1aN0M0), while not increasing the local
recurrence rate. Additionally, it could imply that the size of
the surgical margin is not relevant and not related to disease
progression, as long as the tumor is completely excised.
Moreover, further potential advantages of mini-margin NSS
are in favor of preservation of renal parenchyma, and with a
lower incidence of major blood supply vessel and collecting
system damage, the latter evolving toward urinary leakage,
urinoma, and urinary ﬁstula if undetected and not repaired
during surgery, especially when tumor locates centurally.
5. Conclusions
Mini-margin NSS is as safe and eﬀective as 1cm-NSS and
RN in treating early localized RCC 4cm or less. It provides
excellent renal function preservation, favorable long-term
progression-free survival, lower complication rate, and is not
associated with an increased risk of local recurrence.
Abbreviations and Acronyms
RCC: Renal cell carcinoma
NSS: Nephron sparing surgery
RN: Radical nephrectomy.
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